Center for Medicine
Department of Rheumatology and Clinical Immunology & Center for Chronic Immunodeficiency
Medical Center – University of Freiburg
Breisacher Str. 115
79106 Freiburg i. Brsg.
- +49 (0) 761/ 270 – 34480
- reinhard.voll@uniklinik-freiburg.de
- Homepage
Current position
W3 Professor, Director, Department of Rheumatology and Clinical Immunology,
Center for Medicine, Medical Center – University of Freiburg
Academic training
| 1984 – 1991 | Study of Medicine in Erlangen |
Scientific qualifications
| 2004 | Habilitation in Internal Medicine, University of Erlangen-Nürnberg (Mentor: Prof. Dr. med. Drs. h.c. Joachim R. Kalden) |
| 1993 | Dissertation in Medicine, University of Erlangen-Nürnberg (Supervisor: Prof. Dr. med. Bernhard Fleckenstein) |
Postgraduate Positions
| since 2010 | W3 Professor, Director, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg |
| 2003 – 2010 | Consultant and Group leader, Department of Rheumatology and Clinical Immunology, University Hospital Erlangen |
| 1999 – 2003 | Resident, Department of Internal Medicine 3 (Rheumatology and Clinical Immunology, Hematology, Oncology), University Hospital Erlangen |
| 1996 – 1998 | Postdoctorate (DFG), Laboratory of Dr. Sankar Ghosh, Section of Immunobiology, Yale University School of Medicine, New Haven, USA |
| 1995 – 1996 | Resident, Department of Rheumatology and Clinical Immunology, Hematology, Oncology, University Hospital Erlangen |
| 1993 – 1994 | Postdoctorate, Max-Planck-Society, Clinical Research Units for Rheumatology, University Hospital Erlangen |
| 1991 – 1992 | Assistant physician, Department of Rheumatology and Clinical Immunology, Hematology, Oncology, University Hospital Erlangen |
Miscellaneous (Honors, Awards)
| 2009 | Prize for Clinical Research, Glaxo-SmithKline Foundation |
| 2004 | Fellow of the ACR-EULAR Exchange Program |
Publications based on CRC1160 funding
Jacobsen, E. M., D. Fabricius, M. Class, F. Topfstedt, R. Lorenzetti, I. Janowska, F. Schmidt, J. Staniek, M. Zernickel, T. Stamminger, A. N. Dietz, A. Zellmer, M. Hecht, P. Rauch, C. Blum, C. Ludwig, B. Jahrsdorfer, H. Schrezenmeier, M. Heeg, B. Mayer, A. Seidel, R. Gross, J. Munch, F. Kirchhoff, S. F. N. Bode, G. Strauss, H. Renk, R. Elling, M. Stich, R.E. Voll, B. Tonshof, A. R. Franz, P. Henneke, K. M. Debatin, M. Rizzi, and A. Janda. 2022. High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection. Nat Commun 13: 7315. doi: 10.1038/s41467-022-35055-1.
Kraemer, A. N., A. L. Schafer, D. T. L. Sprenger, B. Sehnert, J. P. Williams, A. Luo, L. Riechert, Q. Al-Kayyal, H. Dumortier, J. D. Fauny, Z. Winter, K. Heim, M. Hofmann, M. Herrmann, G. Heine, R. E. Voll, and N. Chevalier. 2022. Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice. Front Immunol 13: 933191. doi: 10.3389/fimmu.2022.933191.
Rizzi, M., R. Lorenzetti, K. Fischer, J. Staniek, I. Janowska, A. Troilo, V. Strohmeier, M. Erlacher, M. Kunze, B. Bannert, D. Kyburz, E. Voll, N. Venhoff, and J. Thiel. 2017. Impact of tofacitinib treatment on human B-cells in vitro and in vivo. J Autoimmun 77: 55-66.
Herrtwich L, Nanda I, Evangelou K, Nikolova T, Horn V, Sagar, Erny D, Stefanowski J, Rogell L, Klein C, Gharun K, Follo M, Seidl M, Kremer B, Münke N, Senges J, Fliegauf M, Aschman T, Pfeifer D, Sarrazin S, Sieweke MH, Wagner D, Dierks C, Haaf T, Ness T, Zaiss MM, Voll RE, Deshmukh SD, Prinz M, Goldmann T, Hölscher C, Hauser AE, Lopez-Contreras AJ, Grün D, Gorgoulis V, Diefenbach A, Henneke P, Triantafyllopoulou A. 2016. DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas. Cell. 167(5):1264-1280.
